Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Wealth building investment strategies can empower beginners to grow their finances. Explore effective approaches to start investing wisely.
21,485 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Poet Technologies rose today amid broader AI stock swings. This guide explains what moved the stock, what to watch go...
Is SpaceX a smarter buy than the Magnificent Seven it briefly rivaled in market value? This analysis weighs growth, p...
Stellantis faces a tougher profitability and cash-flow comparison with its peers. But for patient investors, the long...
Unum Group operates in the steady world of employer benefits and personal protection. If three key trends line up—und...
Salesforce unveils a $50 billion buyback as software stocks waver, triggering a fierce debate over whether capital sh...
XRP has faced big swings, yet Ripple’s developments could shift the long-term outlook. This guide maps out scenarios ...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
The White House unveiled a plan to deposit a $1,000 government match into private-sector IRAs for eligible savers sta...
Is Rivian a millionaire-maker stock or a high-risk punt? This guide dives into the catalysts, margins, and scenarios ...
A bold revenue target from Micron points to a surprisingly durable AI demand wave. This piece breaks down what the gu...
As SpaceX hit the public markets, 29 wall street analysts priced in a future packed with satellite internet, reusable...